The global Computational Pathology Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Component (Software, Services), By Application (Disease Diagnosis, Drug Discovery & Development, Academic Research), By Technology (Machine Learning (ML), Natural Language Processing (NLP) Models, Computer Vision, Others), By End-User (Hospitals and Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others).
The computational pathology market is poised for significant growth through 2025, driven by the increasing demand for digital pathology solutions that leverage artificial intelligence (AI) and machine learning (ML) to analyze tissue samples and assist pathologists in diagnosing diseases. Computational pathology allows for the digitization of slides, enabling pathologists to remotely access, analyze, and share medical images in a more efficient and accurate manner. The integration of AI algorithms helps to identify patterns in large datasets, improving the accuracy of diagnoses, particularly in cancer detection, where early detection is critical. This market is expanding as healthcare providers adopt more advanced diagnostic technologies to reduce human error and improve patient outcomes. Additionally, the rise of telemedicine and digital health solutions has contributed to the growth of the computational pathology market, as it facilitates remote consultations and faster diagnostic results. As computational pathology evolves, advancements in image analysis and data management technologies, such as cloud storage and automated image processing, are likely to drive further market growth. North America leads the market, driven by strong healthcare infrastructure, whereas the Asia-Pacific region is expected to see significant growth due to increasing healthcare investments.
The market report analyses the leading companies in the industry including aetherAI, CellaVision, CellCarta, ContextVision AB, Epredia (3DHISTECH Ltd), F. Hoffmann-La Roche Ltd, Hamamatsu Photonics Inc, Huron Technologies International Inc, IBEX, Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Mikroscan Technologies Inc, Nucleai Inc, Olympus Corp, Proscia Inc, Tempus, Visiopharm A/S, and others.
The computational pathology market is seeing a significant trend toward the integration of artificial intelligence (AI) and machine learning (ML) to assist pathologists in diagnosing diseases more accurately and efficiently. AI-powered tools are capable of analyzing large volumes of pathology images, detecting patterns, and identifying anomalies that may be missed by human analysts. This trend is enhancing the capabilities of computational pathology, particularly in areas such as oncology, where the early detection of cancerous cells is critical. AI’s ability to learn from vast datasets is also driving its adoption as a valuable diagnostic support tool.
The shift toward digital pathology and remote diagnostics is a key driver in the computational pathology market. Digital pathology allows pathologists to store, retrieve, and share pathology images electronically, facilitating faster diagnoses, particularly in remote or underserved regions. The COVID-19 pandemic further accelerated the need for telemedicine and remote diagnostic solutions, making computational pathology systems crucial for streamlining healthcare delivery. As healthcare organizations seek ways to improve efficiency and accuracy, the adoption of digital and computational pathology tools continues to grow.
A major opportunity in the computational pathology market lies in the development of AI-driven, personalized pathology solutions. By leveraging machine learning algorithms that can analyze an individual’s pathology images in conjunction with their clinical data, AI tools could help clinicians make more tailored treatment decisions. This could be particularly valuable in oncology, where personalized treatment plans based on genetic profiling and pathology images can improve patient outcomes. Developing integrated platforms that combine pathology with genetic and molecular data could lead to breakthrough innovations in precision medicine.
The Disease Diagnosis segment is expected to lead the computational pathology market by 2025, driven by the increasing reliance on artificial intelligence (AI) and digital pathology solutions in the early detection and diagnosis of various diseases, including cancer and infectious diseases. Computational pathology leverages advanced algorithms to analyze digital images of tissue samples, enabling pathologists to make more accurate, efficient, and timely diagnoses. As the healthcare sector continues to adopt precision medicine and the need for faster and more accurate diagnostic tools intensifies, the disease diagnosis application is anticipated to generate the highest revenue. This segment's growth is also supported by the increasing prevalence of chronic diseases and the need for improved diagnostic workflows in clinical settings.
The machine learning (ML) segment is expected to be the fastest growing in the computational pathology market through 2034, driven by the growing demand for automated, precise diagnostic tools and the increasing volume of digital pathology data. Machine learning algorithms are revolutionizing computational pathology by enhancing the ability to analyze complex medical images, predict disease progression, and improve diagnostic accuracy. With the integration of AI technologies, ML models are becoming critical in supporting pathologists to provide faster and more accurate diagnoses, especially in oncology, neurology, and other specialties. As healthcare systems focus on improving efficiency and precision in diagnostics, the demand for machine learning-powered computational pathology solutions will rise. This technological shift is set to drive rapid growth in the ML segment, making it a leading force in the computational pathology market through 2034.
In China, the computational pathology market is experiencing rapid growth due to the country’s increasing emphasis on technological innovation in healthcare. China’s vast population, coupled with a rising burden of chronic diseases like cancer and cardiovascular conditions, is driving the demand for more accurate and efficient diagnostic tools. The government’s strong support for digital health initiatives, such as the adoption of AI in diagnostics, has fueled the integration of computational pathology systems into hospitals and research institutions. Additionally, China’s expanding biotechnology and pharmaceutical industries are key contributors to the market’s growth, as they actively invest in digital pathology solutions to enhance disease detection and improve healthcare outcomes. The increasing availability of large medical datasets and the country’s focus on precision medicine further accelerate the adoption of computational pathology technologies.
India’s computational pathology market is expanding as the country faces a growing demand for advanced diagnostic solutions to address the increasing prevalence of chronic diseases, particularly cancer. With a rapidly growing healthcare infrastructure and rising investments in digital health, India is witnessing increased adoption of AI-powered pathology tools that enable faster and more accurate diagnoses. As the country shifts toward precision medicine and personalized healthcare, computational pathology plays a critical role in facilitating the targeted treatment of diseases. Additionally, the government’s push to digitize healthcare records and improve access to quality diagnostics across urban and rural regions is creating a favorable environment for the growth of computational pathology in India. The rise of medical research centers and academic collaborations in India also contributes to the market’s expansion.
The United States is a leader in the computational pathology market, driven by advanced healthcare infrastructure, cutting-edge technology, and robust investment in research and development. The rapid adoption of digital pathology solutions, particularly in oncology and rare diseases, is a key factor driving the market’s growth. The growing focus on personalized medicine, where accurate diagnosis and treatment are paramount, is pushing healthcare providers and pharmaceutical companies to adopt AI-driven pathology tools. The U.S. also has a highly collaborative environment for technology and healthcare companies, with partnerships accelerating innovation in computational pathology. Moreover, favorable regulatory frameworks such as the FDA’s support for digital health technologies further strengthen the market’s expansion in the U.S.
Germany is a prominent player in the computational pathology market, benefiting from its strong healthcare infrastructure and a well-established focus on innovation in medical technologies. As the country faces an increasing burden of chronic diseases like cancer and neurological disorders, the need for more efficient and accurate diagnostic solutions is rising. Germany’s emphasis on research and development in healthcare, especially in the biotechnology sector, drives the adoption of computational pathology solutions that improve diagnostic accuracy and speed. Additionally, the German government’s support for digital transformation in healthcare, along with strong regulatory frameworks, provides an enabling environment for computational pathology tools to be integrated into medical practices. The rise in personalized medicine and AI-driven diagnostic tools is expected to continue to propel the market forward.
In France, the computational pathology market is growing due to the country’s ongoing efforts to modernize its healthcare system and integrate digital technologies into medical practices. France has a strong focus on cancer research and treatment, with computational pathology playing a pivotal role in enhancing diagnostic accuracy and improving patient outcomes. The increasing adoption of AI and machine learning to analyze pathology images is driving the demand for computational pathology solutions across hospitals, research centers, and universities. Furthermore, the French government’s push to digitize healthcare and promote innovation in medical technologies, combined with a collaborative environment for biotech firms and healthcare providers, is fostering the growth of the market. As precision medicine becomes more prevalent, the need for accurate, AI-driven diagnostics in France is set to rise.
The Middle East is experiencing significant growth in the computational pathology market, driven by rapid advancements in healthcare infrastructure and increasing investments in digital health technologies. Countries such as the UAE, Saudi Arabia, and Qatar are leading the way in adopting cutting-edge diagnostic tools to address the rising prevalence of chronic diseases like cancer and diabetes. As these countries prioritize innovation in healthcare and the development of personalized medicine, computational pathology plays a crucial role in enabling precise diagnoses and treatment planning. Additionally, the region’s growing focus on medical tourism and the increasing availability of advanced diagnostic tools are driving the demand for AI-powered pathology solutions. Governments in the Middle East are investing heavily in healthcare digitization, further accelerating the adoption of computational pathology technologies across the region.
|
Parameter |
Details |
|
Market Size (2025) |
$745.2 Million |
|
Market Size (2034) |
$1578.8 Million |
|
Market Growth Rate |
8.7% |
|
Segments |
By Component (Software, Services), By Application (Disease Diagnosis, Drug Discovery & Development, Academic Research), By Technology (Machine Learning (ML), Natural Language Processing (NLP) Models, Computer Vision, Others), By End-User (Hospitals and Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
aetherAI, CellaVision, CellCarta, ContextVision AB, Epredia (3DHISTECH Ltd), F. Hoffmann-La Roche Ltd, Hamamatsu Photonics Inc, Huron Technologies International Inc, IBEX, Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Mikroscan Technologies Inc, Nucleai Inc, Olympus Corp, Proscia Inc, Tempus, Visiopharm A/S |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Component
Software
Services
By Application
Disease Diagnosis
Drug Discovery & Development
Academic Research
By Technology
Machine Learning (ML)
-Deep Learning
-Others
Natural Language Processing (NLP) Models
Computer Vision
Others
By End-User
Hospitals and Diagnostic Labs
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
aetherAI
CellaVision
CellCarta
ContextVision AB
Epredia (3DHISTECH Ltd)
F. Hoffmann-La Roche Ltd
Hamamatsu Photonics Inc
Huron Technologies International Inc
IBEX
Koninklijke Philips N.V.
Leica Biosystems Nussloch GmbH
Mikroscan Technologies Inc
Nucleai Inc
Olympus Corp
Proscia Inc
Tempus
Visiopharm A/S
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Computational Pathology Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Computational Pathology Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Computational Pathology Market Size by Segments, 2018- 2024
Key Statistics, 2024
Computational Pathology Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Computational Pathology Types, 2018- 2024
Computational Pathology Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Computational Pathology Applications, 2018- 2024
8. Computational Pathology Market Size Outlook by Segments, 2024- 2034
By Component
Software
Services
By Application
Disease Diagnosis
Drug Discovery & Development
Academic Research
By Technology
Machine Learning (ML)
-Deep Learning
-Others
Natural Language Processing (NLP) Models
Computer Vision
Others
By End-User
Hospitals and Diagnostic Labs
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Others
9. Computational Pathology Market Size Outlook by Region
North America
Key Market Dynamics
North America Computational Pathology Market Size Outlook by Type, USD Million, 2021-2034
North America Computational Pathology Market Size Outlook by Application, USD Million, 2021-2034
North America Computational Pathology Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Computational Pathology Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Computational Pathology Market Size Outlook by Type, USD Million, 2021-2034
Europe Computational Pathology Market Size Outlook by Application, USD Million, 2021-2034
Europe Computational Pathology Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Computational Pathology Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Computational Pathology Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Computational Pathology Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Computational Pathology Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Computational Pathology Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Computational Pathology Market Size Outlook by Type, USD Million, 2021-2034
South America Computational Pathology Market Size Outlook by Application, USD Million, 2021-2034
South America Computational Pathology Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Computational Pathology Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Computational Pathology Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Computational Pathology Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Computational Pathology Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Computational Pathology Market Size Outlook by Country, USD Million, 2021-2034
10. United States Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Computational Pathology Market Size Outlook by Type, 2021- 2034
United States Computational Pathology Market Size Outlook by Application, 2021- 2034
United States Computational Pathology Market Size Outlook by End-User, 2021- 2034
11. Canada Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Computational Pathology Market Size Outlook by Type, 2021- 2034
Canada Computational Pathology Market Size Outlook by Application, 2021- 2034
Canada Computational Pathology Market Size Outlook by End-User, 2021- 2034
12. Mexico Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Computational Pathology Market Size Outlook by Type, 2021- 2034
Mexico Computational Pathology Market Size Outlook by Application, 2021- 2034
Mexico Computational Pathology Market Size Outlook by End-User, 2021- 2034
13. Germany Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Computational Pathology Market Size Outlook by Type, 2021- 2034
Germany Computational Pathology Market Size Outlook by Application, 2021- 2034
Germany Computational Pathology Market Size Outlook by End-User, 2021- 2034
14. France Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
France Computational Pathology Market Size Outlook by Type, 2021- 2034
France Computational Pathology Market Size Outlook by Application, 2021- 2034
France Computational Pathology Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Computational Pathology Market Size Outlook by Type, 2021- 2034
United Kingdom Computational Pathology Market Size Outlook by Application, 2021- 2034
United Kingdom Computational Pathology Market Size Outlook by End-User, 2021- 2034
16. Spain Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Computational Pathology Market Size Outlook by Type, 2021- 2034
Spain Computational Pathology Market Size Outlook by Application, 2021- 2034
Spain Computational Pathology Market Size Outlook by End-User, 2021- 2034
17. Italy Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Computational Pathology Market Size Outlook by Type, 2021- 2034
Italy Computational Pathology Market Size Outlook by Application, 2021- 2034
Italy Computational Pathology Market Size Outlook by End-User, 2021- 2034
18. Benelux Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Computational Pathology Market Size Outlook by Type, 2021- 2034
Benelux Computational Pathology Market Size Outlook by Application, 2021- 2034
Benelux Computational Pathology Market Size Outlook by End-User, 2021- 2034
19. Nordic Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Computational Pathology Market Size Outlook by Type, 2021- 2034
Nordic Computational Pathology Market Size Outlook by Application, 2021- 2034
Nordic Computational Pathology Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Computational Pathology Market Size Outlook by Type, 2021- 2034
Rest of Europe Computational Pathology Market Size Outlook by Application, 2021- 2034
Rest of Europe Computational Pathology Market Size Outlook by End-User, 2021- 2034
21. China Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
China Computational Pathology Market Size Outlook by Type, 2021- 2034
China Computational Pathology Market Size Outlook by Application, 2021- 2034
China Computational Pathology Market Size Outlook by End-User, 2021- 2034
22. India Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
India Computational Pathology Market Size Outlook by Type, 2021- 2034
India Computational Pathology Market Size Outlook by Application, 2021- 2034
India Computational Pathology Market Size Outlook by End-User, 2021- 2034
23. Japan Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Computational Pathology Market Size Outlook by Type, 2021- 2034
Japan Computational Pathology Market Size Outlook by Application, 2021- 2034
Japan Computational Pathology Market Size Outlook by End-User, 2021- 2034
24. South Korea Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Computational Pathology Market Size Outlook by Type, 2021- 2034
South Korea Computational Pathology Market Size Outlook by Application, 2021- 2034
South Korea Computational Pathology Market Size Outlook by End-User, 2021- 2034
25. Australia Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Computational Pathology Market Size Outlook by Type, 2021- 2034
Australia Computational Pathology Market Size Outlook by Application, 2021- 2034
Australia Computational Pathology Market Size Outlook by End-User, 2021- 2034
26. South East Asia Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Computational Pathology Market Size Outlook by Type, 2021- 2034
South East Asia Computational Pathology Market Size Outlook by Application, 2021- 2034
South East Asia Computational Pathology Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Computational Pathology Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Computational Pathology Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Computational Pathology Market Size Outlook by End-User, 2021- 2034
28. Brazil Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Computational Pathology Market Size Outlook by Type, 2021- 2034
Brazil Computational Pathology Market Size Outlook by Application, 2021- 2034
Brazil Computational Pathology Market Size Outlook by End-User, 2021- 2034
29. Argentina Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Computational Pathology Market Size Outlook by Type, 2021- 2034
Argentina Computational Pathology Market Size Outlook by Application, 2021- 2034
Argentina Computational Pathology Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Computational Pathology Market Size Outlook by Type, 2021- 2034
Rest of South America Computational Pathology Market Size Outlook by Application, 2021- 2034
Rest of South America Computational Pathology Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Computational Pathology Market Size Outlook by Type, 2021- 2034
United Arab Emirates Computational Pathology Market Size Outlook by Application, 2021- 2034
United Arab Emirates Computational Pathology Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Computational Pathology Market Size Outlook by Type, 2021- 2034
Saudi Arabia Computational Pathology Market Size Outlook by Application, 2021- 2034
Saudi Arabia Computational Pathology Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Computational Pathology Market Size Outlook by Type, 2021- 2034
Rest of Middle East Computational Pathology Market Size Outlook by Application, 2021- 2034
Rest of Middle East Computational Pathology Market Size Outlook by End-User, 2021- 2034
34. South Africa Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Computational Pathology Market Size Outlook by Type, 2021- 2034
South Africa Computational Pathology Market Size Outlook by Application, 2021- 2034
South Africa Computational Pathology Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Computational Pathology Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Computational Pathology Market Size Outlook by Type, 2021- 2034
Rest of Africa Computational Pathology Market Size Outlook by Application, 2021- 2034
Rest of Africa Computational Pathology Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
aetherAI
CellaVision
CellCarta
ContextVision AB
Epredia (3DHISTECH Ltd)
F. Hoffmann-La Roche Ltd
Hamamatsu Photonics Inc
Huron Technologies International Inc
IBEX
Koninklijke Philips N.V.
Leica Biosystems Nussloch GmbH
Mikroscan Technologies Inc
Nucleai Inc
Olympus Corp
Proscia Inc
Tempus
Visiopharm A/S
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Component
Software
Services
By Application
Disease Diagnosis
Drug Discovery & Development
Academic Research
By Technology
Machine Learning (ML)
-Deep Learning
-Others
Natural Language Processing (NLP) Models
Computer Vision
Others
By End-User
Hospitals and Diagnostic Labs
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Others
The Global Computational Pathology Market Size is estimated at $745.2 Million in 2025 and is forecast to register an annual growth rate (CAGR) of 8.7% to reach $1578.8 Million by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
aetherAI, CellaVision, CellCarta, ContextVision AB, Epredia (3DHISTECH Ltd), F. Hoffmann-La Roche Ltd, Hamamatsu Photonics Inc, Huron Technologies International Inc, IBEX, Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Mikroscan Technologies Inc, Nucleai Inc, Olympus Corp, Proscia Inc, Tempus, Visiopharm A/S
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume